id | C00001899 |
---|---|
Name | Papaverine |
CAS RN | 58-74-2 |
Standard InChI | InChI=1S/C20H21NO4/c1-22-17-6-5-13(10-18(17)23-2)9-16-15-12-20(25-4)19(24-3)11-14(15)7-8-21-16/h5-8,10-12H,9H2,1-4H3 |
Standard InChI (Main Layer) | InChI=1S/C20H21NO4/c1-22-17-6-5-13(10-18(17)23-2)9-16-15-12-20(25-4)19(24-3)11-14(15)7-8-21-16/h5-8,10-12H,9H2,1-4H3 |
Phytochemical cluster | No. 4 |
---|---|
KCF-S cluster | No. 1165 |
By standard InChI | CHEMBL19224 |
---|---|
By standard InChI Main Layer | CHEMBL19224 |
By LinkDB | C06533 |
---|
By CAS RN | D010208 |
---|
class name | count |
---|---|
eudicotyledons | 1 |
asterids | 1 |
family name | count |
---|---|
Papaveraceae | 1 |
Apocynaceae | 1 |
KNApSAcK organism | *ID | *family | *plant class | *kingdom |
---|---|---|---|---|
Papaver somniferum | 3469 | Papaveraceae | eudicotyledons | Viridiplantae |
Rauvolfia serpentina | 4060 | Apocynaceae | asterids | Viridiplantae |
accession | description | class description | compound | assay ID (# of activities) |
# of diseases
(OMIM / KEGG) |
---|---|---|---|---|---|
P10635 | Cytochrome P450 2D6 | Cytochrome P450 2D6 | CHEMBL19224 |
CHEMBL1614110
(3)
CHEMBL1741321
(2)
CHEMBL1909136 (2) |
1 / 0 |
Q16637 | Survival motor neuron protein | Unclassified protein | CHEMBL19224 |
CHEMBL1613842
(1)
|
4 / 2 |
P21728 | D(1A) dopamine receptor | Dopamine receptor | CHEMBL19224 |
CHEMBL1909139
(2)
|
0 / 0 |
P35354 | Prostaglandin G/H synthase 2 | Oxidoreductase | CHEMBL19224 |
CHEMBL1909131
(2)
|
0 / 3 |
Q12809 | Potassium voltage-gated channel subfamily H member 2 | KCNH, Kv10-12.x (Ether-a-go-go) | CHEMBL19224 |
CHEMBL1676103
(1)
CHEMBL1909190
(2)
|
2 / 2 |
P08246 | Neutrophil elastase | S1A | CHEMBL19224 |
CHEMBL1909195
(2)
|
2 / 1 |
P33765 | Adenosine receptor A3 | Adenosine receptor | CHEMBL19224 |
CHEMBL1909215
(2)
|
0 / 0 |
Q16539 | Mitogen-activated protein kinase 14 | p38 | CHEMBL19224 |
CHEMBL1909201
(2)
|
0 / 0 |
P49146 | Neuropeptide Y receptor type 2 | Neuropeptide Y receptor | CHEMBL19224 |
CHEMBL1909176
(2)
|
0 / 0 |
Q13370 | cGMP-inhibited 3',5'-cyclic phosphodiesterase B | PDE_3B | CHEMBL19224 |
CHEMBL762675
(1)
CHEMBL909388
(1)
CHEMBL1827311 (1) |
0 / 0 |
P29466 | Caspase-1 | C14 | CHEMBL19224 |
CHEMBL1909193
(2)
|
0 / 0 |
P17252 | Protein kinase C alpha type | Alpha | CHEMBL19224 |
CHEMBL1909198
(2)
|
0 / 0 |
P27361 | Mitogen-activated protein kinase 3 | Erk | CHEMBL19224 |
CHEMBL1909199
(2)
|
0 / 0 |
P14780 | Matrix metalloproteinase-9 | M10A | CHEMBL19224 |
CHEMBL1909197
(2)
|
2 / 2 |
O15245 | Solute carrier family 22 member 1 | Drug uniporter | CHEMBL19224 |
CHEMBL993349
(1)
|
0 / 0 |
Q92793 | CREB-binding protein | Enzyme | CHEMBL19224 |
CHEMBL1614162
(2)
CHEMBL1614333
(2)
CHEMBL1614040 (2) CHEMBL1614026 (2) |
1 / 1 |
O75604 | Ubiquitin carboxyl-terminal hydrolase 2 | Enzyme | CHEMBL19224 |
CHEMBL1614331
(1)
|
0 / 0 |
P02545 | Prelamin-A/C | Unclassified protein | CHEMBL19224 |
CHEMBL1614544
(1)
|
11 / 10 |
P16473 | Thyrotropin receptor | Glycohormone receptor | CHEMBL19224 |
CHEMBL1614281
(2)
CHEMBL1614361
(3)
|
3 / 2 |
P00918 | Carbonic anhydrase 2 | Lyase | CHEMBL19224 |
CHEMBL1909123
(2)
|
1 / 2 |
P07550 | Beta-2 adrenergic receptor | Adrenergic receptor | CHEMBL19224 |
CHEMBL1909092
(2)
|
0 / 1 |
P21397 | Amine oxidase [flavin-containing] A | Oxidoreductase | CHEMBL19224 |
CHEMBL1909169
(2)
|
1 / 1 |
P25021 | Histamine H2 receptor | Histamine receptor | CHEMBL19224 |
CHEMBL1909157
(2)
|
0 / 0 |
P35367 | Histamine H1 receptor | Histamine receptor | CHEMBL19224 |
CHEMBL1909156
(2)
|
0 / 0 |
Q01959 | Sodium-dependent dopamine transporter | Dopamine | CHEMBL19224 |
CHEMBL1909143
(2)
|
1 / 0 |
P08912 | Muscarinic acetylcholine receptor M5 | Acetylcholine receptor | CHEMBL19224 |
CHEMBL1909174
(2)
|
0 / 0 |
P18825 | Alpha-2C adrenergic receptor | Adrenergic receptor | CHEMBL19224 |
CHEMBL1909090
(2)
|
0 / 0 |
P13945 | Beta-3 adrenergic receptor | Adrenergic receptor | CHEMBL19224 |
CHEMBL1909093
(2)
|
0 / 0 |
P25024 | C-X-C chemokine receptor type 1 | CXC chemokine receptor | CHEMBL19224 |
CHEMBL1909127
(2)
|
0 / 0 |
P06241 | Tyrosine-protein kinase Fyn | Src | CHEMBL19224 |
CHEMBL1909204
(2)
|
0 / 0 |
Q08209 | Serine/threonine-protein phosphatase 2B catalytic subunit alpha isoform | Ser_Thr | CHEMBL19224 |
CHEMBL1909202
(2)
|
0 / 0 |
P11712 | Cytochrome P450 2C9 | Cytochrome P450 2C9 | CHEMBL19224 |
CHEMBL1614027
(2)
CHEMBL1741325
(2)
CHEMBL1909135 (2) |
0 / 1 |
P00533 | Epidermal growth factor receptor | TK tyrosine-protein kinase EGFR subfamily | CHEMBL19224 |
CHEMBL1909203
(2)
|
1 / 11 |
P14416 | D(2) dopamine receptor | Dopamine receptor | CHEMBL19224 |
CHEMBL1909140
(2)
|
2 / 0 |
P23219 | Prostaglandin G/H synthase 1 | Oxidoreductase | CHEMBL19224 |
CHEMBL1909130
(2)
|
0 / 0 |
P37288 | Vasopressin V1a receptor | Vasopressin and oxytocin receptor | CHEMBL19224 |
CHEMBL1909120
(2)
|
0 / 0 |
P41145 | Kappa-type opioid receptor | Opioid receptor | CHEMBL19224 |
CHEMBL1909181
(2)
|
0 / 0 |
Q9Y271 | Cysteinyl leukotriene receptor 1 | Leukotriene receptor | CHEMBL19224 |
CHEMBL1909164
(2)
|
0 / 0 |
P29274 | Adenosine receptor A2a | Adenosine receptor | CHEMBL19224 |
CHEMBL1909214
(2)
|
0 / 0 |
P25929 | Neuropeptide Y receptor type 1 | Neuropeptide Y receptor | CHEMBL19224 |
CHEMBL1909175
(2)
|
0 / 0 |
P50052 | Type-2 angiotensin II receptor | Angiotensin receptor | CHEMBL19224 |
CHEMBL1909096
(2)
|
1 / 1 |
P17948 | Vascular endothelial growth factor receptor 1 | Vegfr | CHEMBL19224 |
CHEMBL1909118
(2)
|
0 / 0 |
P41968 | Melanocortin receptor 3 | Melanocortin receptor | CHEMBL19224 |
CHEMBL1909166
(2)
|
1 / 0 |
P00352 | Retinal dehydrogenase 1 | Enzyme | CHEMBL19224 |
CHEMBL1614458
(1)
|
0 / 0 |
P17405 | Sphingomyelin phosphodiesterase | Enzyme | CHEMBL19224 |
CHEMBL943086
(1)
|
2 / 2 |
P11509 | Cytochrome P450 2A6 | Cytochrome P450 2A6 | CHEMBL19224 |
CHEMBL1909133
(2)
|
0 / 0 |
Q16665 | Hypoxia-inducible factor 1-alpha | Transcription Factor | CHEMBL19224 |
CHEMBL1614456
(2)
CHEMBL1613803
(2)
|
0 / 0 |
P51151 | Ras-related protein Rab-9A | Unclassified protein | CHEMBL19224 |
CHEMBL1613838
(1)
|
0 / 0 |
P04035 | 3-hydroxy-3-methylglutaryl-coenzyme A reductase | Oxidoreductase | CHEMBL19224 |
CHEMBL1909158
(2)
|
0 / 0 |
P08913 | Alpha-2A adrenergic receptor | Adrenergic receptor | CHEMBL19224 |
CHEMBL1909088
(2)
|
0 / 0 |
P21917 | D(4) dopamine receptor | Dopamine receptor | CHEMBL19224 |
CHEMBL1909142
(2)
|
0 / 0 |
P30988 | Calcitonin receptor | Calcitonin receptor | CHEMBL19224 |
CHEMBL1909101
(2)
|
0 / 0 |
P35462 | D(3) dopamine receptor | Dopamine receptor | CHEMBL19224 |
CHEMBL1909141
(2)
|
1 / 0 |
P41143 | Delta-type opioid receptor | Opioid receptor | CHEMBL19224 |
CHEMBL1909180
(2)
|
0 / 0 |
Q92731 | Estrogen receptor beta | NR3A2 | CHEMBL19224 |
CHEMBL1909146
(2)
|
0 / 1 |
P41595 | 5-hydroxytryptamine receptor 2B | Serotonin receptor | CHEMBL19224 |
CHEMBL1909104
(2)
|
0 / 0 |
P25101 | Endothelin-1 receptor | Endothelin receptor | CHEMBL19224 |
CHEMBL1909144
(2)
|
0 / 0 |
P30411 | B2 bradykinin receptor | Bradykinin receptor | CHEMBL19224 |
CHEMBL1909100
(2)
|
0 / 0 |
P32245 | Melanocortin receptor 4 | Melanocortin receptor | CHEMBL19224 |
CHEMBL1909167
(2)
|
1 / 0 |
P32238 | Cholecystokinin receptor type A | Cholecystokinin receptor | CHEMBL19224 |
CHEMBL1909129
(2)
|
0 / 0 |
P08311 | Cathepsin G | S1A | CHEMBL19224 |
CHEMBL1909194
(2)
|
0 / 0 |
Q99720 | Sigma non-opioid intracellular receptor 1 | Membrane receptor | CHEMBL19224 |
CHEMBL1909110
(2)
|
1 / 0 |
P03956 | Interstitial collagenase | M10A | CHEMBL19224 |
CHEMBL1909196
(2)
|
0 / 1 |
P32241 | Vasoactive intestinal polypeptide receptor 1 | Vasoactive intestinal peptide receptor | CHEMBL19224 |
CHEMBL1909119
(2)
|
0 / 0 |
Q9Y233 | cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A | PDE_10A | CHEMBL19224 |
CHEMBL1119709
(2)
CHEMBL1629232
(1)
CHEMBL1646316 (1) CHEMBL1780568 (1) CHEMBL1827309 (1) CHEMBL1960211 (1) CHEMBL2187842 (1) |
0 / 0 |
P83916 | Chromobox protein homolog 1 | Unclassified protein | CHEMBL19224 |
CHEMBL1738610
(1)
|
0 / 0 |
P04150 | Glucocorticoid receptor | NR3C1 | CHEMBL19224 |
CHEMBL1909150
(2)
|
0 / 1 |
P08172 | Muscarinic acetylcholine receptor M2 | Acetylcholine receptor | CHEMBL19224 |
CHEMBL1909171
(2)
|
2 / 0 |
P11229 | Muscarinic acetylcholine receptor M1 | Acetylcholine receptor | CHEMBL19224 |
CHEMBL1909170
(2)
|
0 / 0 |
P21554 | Cannabinoid receptor 1 | Cannabinoid receptor | CHEMBL19224 |
CHEMBL1909122
(2)
|
0 / 0 |
P31645 | Sodium-dependent serotonin transporter | Serotonin | CHEMBL19224 |
CHEMBL1909109
(2)
|
2 / 0 |
P04626 | Receptor tyrosine-protein kinase erbB-2 | TK tyrosine-protein kinase EGFR subfamily | CHEMBL19224 |
CHEMBL1909205
(2)
|
5 / 10 |
P20309 | Muscarinic acetylcholine receptor M3 | Acetylcholine receptor | CHEMBL19224 |
CHEMBL1909172
(2)
|
1 / 0 |
P21452 | Substance-K receptor | Neurokinin receptor | CHEMBL19224 |
CHEMBL1909114
(2)
|
0 / 0 |
P51679 | C-C chemokine receptor type 4 | CC chemokine receptor | CHEMBL19224 |
CHEMBL1909125
(2)
|
0 / 0 |
P51681 | C-C chemokine receptor type 5 | CC chemokine receptor | CHEMBL19224 |
CHEMBL1909126
(2)
|
3 / 0 |
P50406 | 5-hydroxytryptamine receptor 6 | Serotonin receptor | CHEMBL19224 |
CHEMBL1909108
(2)
|
0 / 0 |
P18054 | Arachidonate 12-lipoxygenase, 12S-type | Enzyme | CHEMBL19224 |
CHEMBL1614252
(1)
|
2 / 0 |
P41597 | C-C chemokine receptor type 2 | CC chemokine receptor | CHEMBL19224 |
CHEMBL1909124
(2)
|
1 / 0 |
P28482 | Mitogen-activated protein kinase 1 | Erk | CHEMBL19224 |
CHEMBL1613808
(2)
CHEMBL1909200
(2)
|
0 / 0 |
P08575 | Receptor-type tyrosine-protein phosphatase C | Enzyme | CHEMBL19224 |
CHEMBL1909207
(2)
|
2 / 1 |
P05177 | Cytochrome P450 1A2 | Cytochrome P450 1A2 | CHEMBL19224 |
CHEMBL1741322
(2)
CHEMBL1909132
(2)
|
0 / 0 |
O76074 | cGMP-specific 3',5'-cyclic phosphodiesterase | PDE_5A | CHEMBL19224 |
CHEMBL822071
(1)
CHEMBL1909186
(2)
|
0 / 0 |
P03372 | Estrogen receptor | NR3A1 | CHEMBL19224 |
CHEMBL1909145
(2)
|
1 / 1 |
P08588 | Beta-1 adrenergic receptor | Adrenergic receptor | CHEMBL19224 |
CHEMBL1909091
(2)
|
1 / 0 |
P22303 | Acetylcholinesterase | Hydrolase | CHEMBL19224 |
CHEMBL866857
(1)
CHEMBL866858
(1)
CHEMBL866863 (1) CHEMBL1909212 (2) |
1 / 0 |
P28223 | 5-hydroxytryptamine receptor 2A | Serotonin receptor | CHEMBL19224 |
CHEMBL1909211
(2)
|
0 / 0 |
P28335 | 5-hydroxytryptamine receptor 2C | Serotonin receptor | CHEMBL19224 |
CHEMBL1909105
(2)
|
0 / 0 |
P35372 | Mu-type opioid receptor | Opioid receptor | CHEMBL19224 |
CHEMBL1909182
(2)
|
0 / 0 |
P08173 | Muscarinic acetylcholine receptor M4 | Acetylcholine receptor | CHEMBL19224 |
CHEMBL1909173
(2)
|
0 / 0 |
P25103 | Substance-P receptor | Neurokinin receptor | CHEMBL19224 |
CHEMBL1909113
(2)
|
0 / 0 |
P25105 | Platelet-activating factor receptor | PAF receptor | CHEMBL19224 |
CHEMBL1909187
(2)
|
0 / 0 |
P33032 | Melanocortin receptor 5 | Melanocortin receptor | CHEMBL19224 |
CHEMBL1909168
(2)
|
0 / 0 |
P19838 | Nuclear factor NF-kappa-B p105 subunit | Transcription Factor | CHEMBL19224 |
CHEMBL1614274
(1)
CHEMBL1613823
(1)
|
0 / 0 |
P16050 | Arachidonate 15-lipoxygenase | Enzyme | CHEMBL19224 |
CHEMBL1614240
(1)
|
0 / 0 |
P33261 | Cytochrome P450 2C19 | Cytochrome P450 2C19 | CHEMBL19224 |
CHEMBL1613777
(3)
CHEMBL1741323
(2)
CHEMBL1909134 (2) |
1 / 1 |
P08684 | Cytochrome P450 3A4 | Cytochrome P450 3A4 | CHEMBL19224 |
CHEMBL1614108
(2)
CHEMBL1613886
(2)
CHEMBL1741324 (2) CHEMBL1909138 (2) |
0 / 1 |
P05181 | Cytochrome P450 2E1 | Cytochrome P450 2E1 | CHEMBL19224 |
CHEMBL1909137
(2)
|
0 / 0 |
Q16236 | Nuclear factor erythroid 2-related factor 2 | Unclassified protein | CHEMBL19224 |
CHEMBL1737980
(1)
|
0 / 0 |
P23975 | Sodium-dependent noradrenaline transporter | Norepinephrine | CHEMBL19224 |
CHEMBL1909094
(2)
|
1 / 1 |
P25100 | Alpha-1D adrenergic receptor | Adrenergic receptor | CHEMBL19224 |
CHEMBL1909087
(2)
|
0 / 0 |
P30542 | Adenosine receptor A1 | Adenosine receptor | CHEMBL19224 |
CHEMBL1909213
(2)
|
0 / 0 |
Q14432 | cGMP-inhibited 3',5'-cyclic phosphodiesterase A | PDE_3A | CHEMBL19224 |
CHEMBL762675
(1)
CHEMBL909386
(1)
CHEMBL1827310 (1) CHEMBL2187831 (1) |
0 / 0 |
P18089 | Alpha-2B adrenergic receptor | Adrenergic receptor | CHEMBL19224 |
CHEMBL1909089
(2)
|
0 / 0 |
P24557 | Thromboxane-A synthase | Cytochrome P450 5A1 | CHEMBL19224 |
CHEMBL1909116
(2)
|
1 / 1 |
P06239 | Tyrosine-protein kinase Lck | Src | CHEMBL19224 |
CHEMBL1909206
(2)
|
0 / 1 |
O00408 | cGMP-dependent 3',5'-cyclic phosphodiesterase | PDE_2A | CHEMBL19224 |
CHEMBL759849
(1)
CHEMBL768902
(1)
|
0 / 0 |
P25025 | C-X-C chemokine receptor type 2 | CXC chemokine receptor | CHEMBL19224 |
CHEMBL1909128
(2)
|
0 / 0 |
Q9UBT6 | DNA polymerase kappa | Enzyme | CHEMBL19224 |
CHEMBL1794536
(2)
|
0 / 0 |
P40225 | Thrombopoietin | Unclassified protein | CHEMBL19224 |
CHEMBL1614086
(1)
CHEMBL1614034
(1)
|
1 / 1 |
Q96KQ7 | Histone-lysine N-methyltransferase EHMT2 | Enzyme | CHEMBL19224 |
CHEMBL1738442
(2)
|
0 / 0 |
Q14123 | Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1C | PDE_1C | CHEMBL19224 |
CHEMBL760919
(1)
CHEMBL822070
(1)
|
0 / 0 |
P54750 | Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1A | PDE_1A | CHEMBL19224 |
CHEMBL760919
(1)
CHEMBL822070
(1)
|
0 / 0 |
Q01064 | Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1B | PDE_1B | CHEMBL19224 |
CHEMBL760919
(1)
CHEMBL822070
(1)
|
0 / 0 |
P27815 | cAMP-specific 3',5'-cyclic phosphodiesterase 4A | PDE_4A | CHEMBL19224 |
CHEMBL762675
(1)
|
0 / 0 |
Q08499 | cAMP-specific 3',5'-cyclic phosphodiesterase 4D | PDE_4D | CHEMBL19224 |
CHEMBL762675
(1)
|
1 / 0 |
Q07343 | cAMP-specific 3',5'-cyclic phosphodiesterase 4B | PDE_4B | CHEMBL19224 |
CHEMBL762675
(1)
|
0 / 0 |
Q08493 | cAMP-specific 3',5'-cyclic phosphodiesterase 4C | PDE_4C | CHEMBL19224 |
CHEMBL762675
(1)
|
0 / 0 |
Q9NY46 | Sodium channel protein type 3 subunit alpha | SCN alpha, NaV1.x | CHEMBL19224 |
CHEMBL806153
(1)
CHEMBL806154
(1)
|
0 / 0 |
Q99250 | Sodium channel protein type 2 subunit alpha | SCN alpha, NaV1.x | CHEMBL19224 |
CHEMBL806153
(1)
CHEMBL806154
(1)
|
2 / 2 |
P35498 | Sodium channel protein type 1 subunit alpha | SCN alpha, NaV1.x | CHEMBL19224 |
CHEMBL806153
(1)
CHEMBL806154
(1)
|
3 / 2 |
compound | gene | gene name | gene description | interaction | interaction type | form |
reference
pmid |
---|---|---|---|---|---|---|---|
D010208 | 1080 |
CFTR
ABC35 ABCC7 CF CFTR/MRP MRP7 TNR-CFTR dJ760C5.1 |
cystic fibrosis transmembrane conductance regulator (ATP-binding cassette sub-family C, member 7) (EC:3.6.3.49) | Papaverine promotes the reaction [CFTR protein affects the secretion of Chlorides] |
affects secretion
/ increases reaction |
protein |
12714375
|
D010208 | 1080 |
CFTR
ABC35 ABCC7 CF CFTR/MRP MRP7 TNR-CFTR dJ760C5.1 |
cystic fibrosis transmembrane conductance regulator (ATP-binding cassette sub-family C, member 7) (EC:3.6.3.49) | Papaverine results in increased activity of CFTR protein |
increases activity
|
protein |
12714375
|
D010208 | 1543 |
CYP1A1
AHH AHRR CP11 CYP1 P1-450 P450-C P450DX |
cytochrome P450, family 1, subfamily A, polypeptide 1 (EC:1.14.14.1) | Papaverine inhibits the reaction [Tetrachlorodibenzodioxin results in increased activity of CYP1A1 protein] |
decreases reaction
/ increases activity |
protein |
18493746
|
D010208 | 1544 |
CYP1A2
CP12 P3-450 P450(PA) |
cytochrome P450, family 1, subfamily A, polypeptide 2 (EC:1.14.14.1) | Papaverine inhibits the reaction [Tetrachlorodibenzodioxin results in increased activity of CYP1A2 protein] |
decreases reaction
/ increases activity |
protein |
18493746
|
D010208 | 5150 |
PDE7A
HCP1 PDE7 |
phosphodiesterase 7A (EC:3.1.4.17) | Papaverine inhibits the reaction [PDE7A protein results in increased hydrolysis of Cyclic AMP] |
decreases reaction
/ increases hydrolysis |
protein |
10618442
|
D010208 | 6581 |
SLC22A3
EMT EMTH OCT3 |
solute carrier family 22 (organic cation transporter), member 3 | Papaverine inhibits the reaction [SLC22A3 protein results in increased uptake of 1-Methyl-4-phenylpyridinium] |
decreases reaction
/ increases uptake |
protein |
12411423
|
OMIM | preferred title | UniProt |
---|---|---|
#100100 | Abdominal muscles, absence of, with urinary tract abnormality and cryptorchidism |
P20309
|
#614613 | Acrodysostosis 2, with or without hormone resistance; acrdys2 |
Q08499
|
#103780 | Alcohol dependence |
P08172
P14416 P31645 |
#614373 | Amyotrophic lateral sclerosis 16, juvenile; als16 |
Q99720
|
#602025 | Body mass index quantitative trait locus 9; bmiq9 |
P41968
|
#300615 | Brunner syndrome |
P21397
|
#115200 | Cardiomyopathy, dilated, 1a; cmd1a |
P02545
|
#212112 | Cardiomyopathy, dilated, with hypergonadotropic hypogonadism |
P02545
|
#605588 | Charcot-marie-tooth disease, axonal, type 2b1; cmt2b1 |
P02545
|
#114500 | Colorectal cancer; crc |
P18054
|
#162800 | Cyclic neutropenia |
P08246
|
#612522 | Diabetes mellitus, insulin-dependent, 22; iddm22 |
P51681
|
#607208 | Dravet syndrome |
P35498
|
#609535 | Drug metabolism, poor, cyp2c19-related |
P33261
|
#608902 | Drug metabolism, poor, cyp2d6-related |
P10635
|
#181350 | Emery-dreifuss muscular dystrophy 2, autosomal dominant; edmd2 |
P02545
|
#613721 | Epileptic encephalopathy, early infantile, 11; eiee11 |
Q99250
|
#133239 | Esophageal cancer |
P18054
|
#615363 | Estrogen resistance; estrr |
P03372
|
#613659 | Gastric cancer |
P04626
|
#137215 | Gastric cancer, hereditary diffuse; hdgc |
P04626
|
#604403 | Generalized epilepsy with febrile seizures plus, type 2; gefsp2 |
P35498
|
#231095 | Ghosal hematodiaphyseal dysplasia; ghdd |
P24557
|
#137800 | Glioma susceptibility 1; glm1 |
P04626
|
#610140 | Heart-hand syndrome, slovenian type |
P02545
|
#609423 | Human immunodeficiency virus type 1, susceptibility to |
P41597
P51681 |
#176670 | Hutchinson-gilford progeria syndrome; hgps |
P02545
|
#603373 | Hyperthyroidism, familial gestational |
P16473
|
#609152 | Hyperthyroidism, nonautoimmune |
P16473
|
#275200 | Hypothyroidism, congenital, nongoitrous, 1; chng1 |
P16473
|
#603932 | Intervertebral disc disease; idd |
P14780
|
#151660 | Lipodystrophy, familial partial, type 2; fpld2 |
P02545
|
#613688 | Long qt syndrome 2; lqt2 |
Q12809
|
#211980 | Lung cancer |
P00533
P04626 |
#608516 | Major depressive disorder; mdd |
P08172
|
#248370 | Mandibuloacral dysplasia with type a lipodystrophy; mada |
P02545
|
%300852 | Mental retardation, x-linked 88; mrx88 |
P50052
|
#613073 | Metaphyseal anadysplasia 2; mandp2 |
P14780
|
#609634 | Migraine, familial hemiplegic, 3; fhm3 |
P35498
|
#126200 | Multiple sclerosis, susceptibility to; ms |
P08575
|
#613205 | Muscular dystrophy, congenital, lmna-related |
P02545
|
#159001 | Muscular dystrophy, limb-girdle, type 1b; lgmd1b |
P02545
|
#159900 | Myoclonic dystonia |
P14416
|
#202700 | Neutropenia, severe congenital, 1, autosomal dominant; scn1 |
P08246
|
#257200 | Niemann-pick disease, type a |
P17405
|
#607616 | Niemann-pick disease, type b |
P17405
|
#601665 | Obesity |
P32245
|
#164230 | Obsessive-compulsive disorder; ocd |
P31645
|
#604715 | Orthostatic intolerance |
P23975
|
#259730 | Osteopetrosis, autosomal recessive 3; optb3 |
P00918
|
#167000 | Ovarian cancer |
P04626
|
#613135 | Parkinsonism-dystonia, infantile; pkdys |
Q01959
|
#607276 | Resting heart rate, variation in |
P08588
|
#275210 | Restrictive dermopathy, lethal |
P02545
|
#180849 | Rubinstein-taybi syndrome 1; rsts1 |
Q92793
|
#607745 | Seizures, benign familial infantile, 3; bfis3 |
Q99250
|
#608971 | Severe combined immunodeficiency, autosomal recessive, t cell-negative, b cell-positive, nk cell-positive |
P08575
|
#609620 | Short qt syndrome 1; sqt1 |
Q12809
|
#253300 | Spinal muscular atrophy, type i; sma1 |
Q16637
|
#253550 | Spinal muscular atrophy, type ii; sma2 |
Q16637
|
#253400 | Spinal muscular atrophy, type iii; sma3 |
Q16637
|
#271150 | Spinal muscular atrophy, type iv; sma4 |
Q16637
|
#187950 | Thrombocythemia 1; thcyt1 |
P40225
|
#190300 | Tremor, hereditary essential, 1; etm1 |
P35462
|
#610379 | West nile virus, susceptibility to |
P51681
|
#112100 | Yt blood group antigen |
P22303
|
KEGG | disease name | UniProt |
---|---|---|
H00016 | Oral cancer |
P00533
(related)
P00533 (marker) |
H00017 | Esophageal cancer |
P00533
(related)
P35354 (related) |
H00018 | Gastric cancer |
P00533
(related)
P04626 (related) |
H00022 | Bladder cancer |
P00533
(related)
P04626 (related) |
H00028 | Choriocarcinoma |
P00533
(related)
P03956 (related) P04626 (related) |
H00030 | Cervical cancer |
P00533
(related)
P04626 (related) |
H00042 | Glioma |
P00533
(related)
P00533 (marker) |
H00055 | Laryngeal cancer |
P00533
(related)
P00533 (marker) |
H00241 | Combined proximal and distal renal tubular acidosis (RTA type 3) |
P00918
(related)
|
H00436 | Osteopetrosis |
P00918
(related)
|
H00264 | Charcot-Marie-Tooth disease (CMT) |
P02545
(related)
|
H00294 | Dilated cardiomyopathy (DCM) |
P02545
(related)
|
H00420 | Familial partial lipodystrophy (FPL) |
P02545
(related)
|
H00563 | Emery-Dreifuss muscular dystrophy |
P02545
(related)
|
H00590 | Congenital muscular dystrophies (CMD/MDC) |
P02545
(related)
|
H00593 | Limb-girdle muscular dystrophy (LGMD) |
P02545
(related)
|
H00601 | Hutchinson-Gilford progeria syndrome |
P02545
(related)
|
H00663 | Restrictive dermopathy |
P02545
(related)
|
H00665 | Mandibuloacral dysplasia |
P02545
(related)
|
H01216 | Left ventricular noncompaction (LVNC) |
P02545
(related)
|
H00026 | Endometrial Cancer |
P03372
(marker)
P04626 (related) Q92731 (marker) |
H00599 | 46,XX disorders of sex development (Disorders related to androgen excess) |
P04150
(related)
|
H00019 | Pancreatic cancer |
P04626
(related)
|
H00027 | Ovarian cancer |
P04626
(related)
|
H00031 | Breast cancer |
P04626
(related)
P04626 (marker) |
H00046 | Cholangiocarcinoma |
P04626
(related)
P35354 (related) |
H00093 | Combined immunodeficiencies (CIDs) |
P06239
(related)
|
H00079 | Asthma |
P07550
(related)
|
H00100 | Neutropenic disorders |
P08246
(related)
|
H00091 | T-B+Severe combined immunodeficiencies (SCIDs) |
P08575
(related)
|
H00036 | Osteosarcoma |
P08684
(marker)
|
H01205 | Coumarin resistance |
P11712
(related)
|
H00025 | Penile cancer |
P14780
(related)
P35354 (related) |
H00479 | Metaphyseal dysplasias |
P14780
(related)
|
H00250 | Congenital nongoitrous hypothyroidism (CHNG) |
P16473
(related)
|
H01269 | Congenital hyperthyroidism |
P16473
(related)
|
H00137 | Niemann-Pick disease (NPD) typeA and B |
P17405
(related)
|
H00424 | Defects in the degradation of sphingomyelin |
P17405
(related)
|
H00548 | Brunner syndrome |
P21397
(related)
|
H01031 | Orthostatic intolerance (OI) |
P23975
(related)
|
H00490 | Diaphyseal dysplasia with anemia (Ghosal) |
P24557
(related)
|
H01171 | Poor drug metabolism (PM) |
P33261
(related)
|
H00775 | Familial or sporadic hemiplegic migraine |
P35498
(related)
|
H00783 | Febrile seizures |
P35498
(related)
|
H00227 | Congenital amegakaryocytic thrombocytopenia (CAMT) |
P40225
(marker)
|
H00480 | Non-syndromic X-linked mental retardation |
P50052
(related)
|
H00720 | Long QT syndrome |
Q12809
(related)
|
H00725 | Short QT syndrome |
Q12809
(related)
|
H00455 | Spinal muscular atrophy (SMA) |
Q16637
(related)
Q16637 (related) |
H00504 | Rubinstein-Taybi syndrome |
Q92793
(related)
|
H00606 | Early infantile epileptic encephalopathy |
Q99250
(related)
|
H00806 | Benign familial neonatal and infantile epilepsies |
Q99250
(related)
|
MeSH disease | OMIM | compound | disease name | evidence type |
reference
pmid |
---|---|---|---|---|---|
D001037 | D010208 | Aphasia |
marker/mechanism
|
8613866
|
|
D001145 | D010208 | Arrhythmias, Cardiac |
marker/mechanism
therapeutic |
2461650
18858160 |
|
D001157 | D010208 | Arterial Occlusive Diseases |
marker/mechanism
|
3809473
8451424 |
|
D054537 | D010208 | Atrioventricular Block |
marker/mechanism
|
1422403
|
|
D001766 | D010208 | Blindness |
marker/mechanism
|
19901231
|
|
D001919 | D010208 | Bradycardia |
marker/mechanism
|
19961315
|
|
D002375 | D010208 | Catalepsy |
marker/mechanism
|
1033561
|
|
D002539 | D010208 | Cerebral Arterial Diseases |
therapeutic
|
9726476
|
|
D002637 | D010208 | Chest Pain |
marker/mechanism
|
2750660
|
|
D015862 | D010208 | Choroid Diseases |
marker/mechanism
|
19901231
|
|
D003128 | D010208 | COMA |
marker/mechanism
|
3366170
|
|
D004244 | D010208 | Dizziness |
marker/mechanism
|
3366170
|
|
D004409 | D010208 | Dyskinesia, Drug-Induced |
therapeutic
|
1172755
|
|
D004414 | D010208 | Dyspareunia |
marker/mechanism
|
1296038
1719248 |
|
D004487 | D010208 | Edema |
marker/mechanism
|
11549511
|
|
D007172 | D010208 | Erectile Dysfunction |
therapeutic
|
1296038
1589286 1737261 1984099 2278150 2327828 2366292 2617964 2908935 2917481 3175561 3215253 3363769 3640652 3687629 7735362 9607891 10098948 14999218 |
|
D005094 | D010208 | Exophthalmos |
marker/mechanism
|
19901231
|
|
D005155 | D010208 | Facial Nerve Diseases |
marker/mechanism
|
12513030
|
|
D005158 | D010208 | Facial Paralysis |
marker/mechanism
|
9918178
12513030 17977279 |
|
D005355 | D010208 | Fibrosis |
marker/mechanism
|
11549511
|
|
D006319 | D010208 | Hearing Loss, Sensorineural |
marker/mechanism
|
18726058
|
|
D006406 | D010208 | Hematoma |
marker/mechanism
|
3762853
|
|
D006429 | D010208 | Hemiplegia |
marker/mechanism
|
8613866
|
|
D006505 | D010208 | Hepatitis |
marker/mechanism
|
4029887
|
|
D006521 | D010208 | Hepatitis, Chronic |
marker/mechanism
|
3949106
|
|
D006940 | D010208 | Hyperemia |
marker/mechanism
|
2358592
3881002 6240483 8287414 8601879 8892781 9840701 11249884 17351955 18568317 |
|
D007022 | D010208 | Hypotension |
marker/mechanism
|
999414
2835134 16984954 19604547 19961315 |
|
D018783 | D010208 | Impotence, Vasculogenic |
therapeutic
|
1719248
2038782 |
|
D007238 | D010208 | Infarction |
marker/mechanism
|
19901231
|
|
D020766 | D010208 | Intracranial Embolism |
marker/mechanism
|
16283980
|
|
D019586 | D010208 | Intracranial Hypertension |
marker/mechanism
|
9726476
|
|
D007565 | D010208 | Jaundice |
marker/mechanism
|
3949106
|
|
D008103 | D010208 | Liver Cirrhosis |
marker/mechanism
|
3949106
|
|
D008133 | D010208 | Long QT Syndrome |
marker/mechanism
|
2044564
2334953 2605630 7511988 |
|
D018908 | D010208 | Muscle Weakness |
marker/mechanism
|
3366170
|
|
D015878 | D010208 | Mydriasis |
marker/mechanism
|
12513030
|
|
D009461 | D010208 | Neurologic Manifestations |
marker/mechanism
|
7847211
|
|
D010291 | D010208 | Paresis |
therapeutic
|
3762853
11145478 |
|
D010411 | D010208 | Penile Induration |
marker/mechanism
therapeutic |
1589286
2908935 3363769 7713130 |
|
D011183 | D010208 | Postoperative Complications |
marker/mechanism
|
9918178
18726058 |
|
D011317 | D010208 | Priapism |
marker/mechanism
|
1296038
1589286 1719248 1984077 2278150 2327828 2524805 2908935 2917481 7713130 14999218 |
|
D012131 | D010208 | Respiratory Insufficiency |
marker/mechanism
|
7847211
|
|
D054138 | D010208 | Sinus Arrest, Cardiac |
marker/mechanism
|
19961315
|
|
D013035 | D010208 | Spasm |
therapeutic
|
47907
|
|
D017180 | D010208 | Tachycardia, Ventricular |
marker/mechanism
|
2299067
7511988 8032075 8892781 |
|
D013927 | D010208 | Thrombosis |
marker/mechanism
|
8451424
|
|
D016171 | D010208 | Torsades de Pointes |
marker/mechanism
|
2044564
2605630 |
|
D020301 | D010208 | Vasospasm, Intracranial |
therapeutic
|
7847211
7900600 8010275 9726476 11145478 18726058 19057314 19901231 |
|
D014693 | D010208 | Ventricular Fibrillation |
marker/mechanism
|
1772671
|
|
D000160 | D010208 | Vestibulocochlear Nerve Diseases |
marker/mechanism
|
18726058
|